Advertisement

Topics

Epeius Biotechnologies Corporation Company Profile

06:34 EDT 21st March 2019 | BioPortfolio

Epeius Biotechnologies Corporation is a privately held biopharmaceutical company focused on research, development, and commercialization of the first truly effective targeted delivery system (TDS) that can be injected directly into a vein and deliver genes and/or molecular therapeutics preferentially to cancerous tumors that have spread throughout the body (metastatic cancer), without eliciting systemic side effects or organ damage. These features make the targeted vectors more effective and less toxic than conventional medicines.
Targeted gene delivery, one of the primary applications of the company’s TDS technology, is considered to be the “holy grail” of gene therapy. Recently, Epeius Biotechnologies has achieved a highly significant milestone with its leading product, REXIN-GTM, which has been demonstrated to cause shrinkage and necrosis of tumors in human patients suffering from metastatic cancer. Further, REXIN-GTM is the first tumor-targeted injectable gene therapy vector that has been approved by both the U.S. FDA and the Philippine BFAD for use in Phase I/II clinical trials.

Location

475 Huntington Drive,
San Marino
California
91108
United States of America

Contact

Phone: 626-441-6695
Fax: 626-441-6692
Email: info@epeiusbiotech.com


News Articles [256 Associated News Articles listed on BioPortfolio]

DGAP-Stimmrechte: Elanix Biotechnologies AG (deutsch)

Elanix Biotechnologies AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung DGAP Stimmrechtsmitteilung: Elanix Biotechnologies AG Elanix Biotechnologies AG: Veröf...

DGAP-Gesamtstimmrechtsmitteilung: Elanix Biotechnologies AG (deutsch)

Elanix Biotechnologies AG: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 41 WpHG mit dem Ziel der europaweiten Verbreitung DGAP Gesamtstimmrechtsmitteilung: Elanix Biotechnologies AG / Ve.....

Deals this week: SQZ Biotechnologies, Immugenyx, Berkeley Lights

SQZ Biotechnologies has expanded its collaboration with Roche to develop products for oncology indications using cellular therapy. The two companies...Read More... The post Deals this week: SQZ Biotec...

DGAP-Adhoc: Elanix Biotechnologies AG: Rücktritt im Aufsichtsrat (deutsch)

Elanix Biotechnologies AG: Rücktritt im Aufsichtsrat DGAP-Ad-hoc: Elanix Biotechnologies AG / Schlagwort(e): Personalie Elanix Biotechnologies AG: Rücktritt im Aufsichtsrat 14.02.2019 / 09:21 CET/C....

UNITY Biotechnologies Selects a New Senolytic Candidate

Another senolytic drug candidate has entered development at

DGAP-Adhoc: Elanix Biotechnologies AG: Widerruf der Bestellung von Herrn Tomas J. Svoboda (CEO) als Vorstandsmitglied (deutsch)

Elanix Biotechnologies AG: Widerruf der Bestellung von Herrn Tomas J. Svoboda (CEO) als Vorstandsmitglied DGAP-Ad-hoc: Elanix Biotechnologies AG / Schlagwort(e): Personalie Elanix Biotechnologies A...

DGAP-Adhoc: Elanix Biotechnologies AG: Frau Professor Laurent-Applegate, Gründerin und Interims-Vorstand, kündigt Verkauf von Aktien der Elanix Biotechnologies AG an (deutsch)

Elanix Biotechnologies AG: Frau Professor Laurent-Applegate, Gründerin und Interims-Vorstand, kündigt Verkauf von Aktien der Elanix Biotechnologies AG an DGAP-Ad-hoc: Elanix Biotechnologies AG / Sc....

Hoverink Biotechnologies, Inc., today announced that they have completed an application with the USPTO for MAXKAFLEN®. Hoverink Biotechnologies, Inc plans to develop and commercialize MAXKAFLEN® a cattle and swine antibiotic.

Overview LOS ANGELES, CA, Nov. 12, 2018 (GLOBE NEWSWIRE) -- On September 26, 2018 We filed trademark applications covering: MAXKAFLEN® Word Mark               MAXKAFLEN Goods and...

PubMed Articles [22 Associated PubMed Articles listed on BioPortfolio]

Response to Open Peer Commentaries on "Patenting Foundational Technologies: Lessons From CRISPR and Other Core Biotechnologies".

Post-cervical artificial insemination in porcine: The technique that came to stay.

The porcine industry is of great importance worldwide, and so any technological innovation in one or more of the associated production areas is of interest for meat production. Among such innovations ...

Enhancing Yeast Alcoholic Fermentations.

The production of ethanol by yeast fermentation represents the largest of all global biotechnologies. Consequently, the yeast Saccharomyces cerevisiae is the world's premier industrial microorganism, ...

Preparation of magnetic microspheres functionalized by lanthanide oxides for selective isolation of bovine hemoglobin.

The isolation and depletion of highly-abundant proteins and peptides is of vital importance for the screening and monitoring of biomarkers which are low stoichiometry in proteomics and protein-based b...

Healthcare professionals', students', patients' and donors' perceptions of stem cell research and therapy: a systematic review protocol.

Stem cell research (SCR) and the biomedical potential of developing therapies are crucial topics in biomedicine. Like other biotechnologies, stem cells are context specific entities understood through...

Clinical Trials [0 Results]

None

Companies [285 Associated Companies listed on BioPortfolio]

Epeius Biotechnologies Corp.

Epeius Biotechnologies Corporation is a privately held biopharmaceutical company dedicated to the advancement of genetic medicine with the development and commercialization of its leading oncology pro...

Epeius Biotechnologies Corporation

Epeius Biotechnologies Corporation is a privately held biopharmaceutical company focused on research, development, and commercialization of the first truly effective targeted delivery system (TDS) tha...

RAN Biotechnologies

Based in Beverly, MA, USA, RAN Biotechnologies, Inc., www.ranbiotechnologies.com, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...

Open Therapeutics

Open Therapeutics (http://OpenTherapeutics.org) is a crowdsourcing life science firm that creates and attracts therapeutic biotechnologies and crowdsources them for the global ...

Genemed Biotechnologies Incorporated

Genemed Biotechnologies Inc. provides high quality contract manufacturing services for a wide variety of research and diagnostic products including native or recombinant proteins and nucleotides

More Information about "Epeius Biotechnologies Corporation" on BioPortfolio

We have published hundreds of Epeius Biotechnologies Corporation news stories on BioPortfolio along with dozens of Epeius Biotechnologies Corporation Clinical Trials and PubMed Articles about Epeius Biotechnologies Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Epeius Biotechnologies Corporation Companies in our database. You can also find out about relevant Epeius Biotechnologies Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record